Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neuroendocrine Tumors | 39 | 2024 | 650 | 7.220 |
Why?
|
Medulloblastoma | 19 | 2022 | 678 | 1.840 |
Why?
|
Pancreatic Neoplasms | 18 | 2023 | 5349 | 1.430 |
Why?
|
Neuroectodermal Tumors, Primitive | 7 | 2023 | 136 | 1.320 |
Why?
|
Cerebellar Neoplasms | 10 | 2022 | 586 | 1.290 |
Why?
|
Brain Neoplasms | 36 | 2024 | 8985 | 1.230 |
Why?
|
Hedgehog Proteins | 12 | 2022 | 769 | 1.070 |
Why?
|
Oligodendroglioma | 5 | 2019 | 279 | 0.940 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 22 | 2024 | 11713 | 0.870 |
Why?
|
TOR Serine-Threonine Kinases | 6 | 2014 | 2058 | 0.810 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2023 | 346 | 0.810 |
Why?
|
Intestinal Neoplasms | 6 | 2023 | 311 | 0.760 |
Why?
|
Dacarbazine | 3 | 2013 | 560 | 0.760 |
Why?
|
Paraganglioma | 1 | 2022 | 142 | 0.730 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 5 | 2019 | 494 | 0.710 |
Why?
|
Pheochromocytoma | 1 | 2022 | 328 | 0.700 |
Why?
|
Octreotide | 6 | 2024 | 153 | 0.680 |
Why?
|
Chromosomes, Human, Pair 19 | 4 | 2013 | 347 | 0.620 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2019 | 311 | 0.610 |
Why?
|
Stomach Neoplasms | 6 | 2024 | 1424 | 0.590 |
Why?
|
Neural Stem Cells | 4 | 2021 | 884 | 0.580 |
Why?
|
Glioma | 14 | 2023 | 3420 | 0.580 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2022 | 733 | 0.550 |
Why?
|
Ependymoma | 4 | 2024 | 320 | 0.520 |
Why?
|
Glioblastoma | 13 | 2024 | 3482 | 0.490 |
Why?
|
Antineoplastic Agents | 9 | 2020 | 13627 | 0.470 |
Why?
|
Gene Expression Regulation, Neoplastic | 18 | 2023 | 8512 | 0.460 |
Why?
|
Esophageal Neoplasms | 4 | 2024 | 1648 | 0.460 |
Why?
|
Repressor Proteins | 5 | 2022 | 2982 | 0.450 |
Why?
|
Colorectal Neoplasms | 14 | 2019 | 6853 | 0.430 |
Why?
|
Xenograft Model Antitumor Assays | 13 | 2020 | 3583 | 0.430 |
Why?
|
Practice Guidelines as Topic | 5 | 2023 | 7475 | 0.430 |
Why?
|
MicroRNAs | 8 | 2019 | 3787 | 0.420 |
Why?
|
Supratentorial Neoplasms | 1 | 2013 | 159 | 0.410 |
Why?
|
Carcinoid Tumor | 5 | 2020 | 228 | 0.390 |
Why?
|
Neoplastic Stem Cells | 6 | 2023 | 1347 | 0.380 |
Why?
|
Rhabdoid Tumor | 3 | 2020 | 210 | 0.380 |
Why?
|
Tumor Microenvironment | 6 | 2024 | 3844 | 0.380 |
Why?
|
Sirolimus | 7 | 2013 | 1547 | 0.370 |
Why?
|
Molecular Targeted Therapy | 5 | 2016 | 2803 | 0.370 |
Why?
|
Disease-Free Survival | 17 | 2022 | 6831 | 0.360 |
Why?
|
Isocitrate Dehydrogenase | 6 | 2015 | 929 | 0.360 |
Why?
|
Teratoma | 3 | 2020 | 403 | 0.360 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2022 | 3484 | 0.340 |
Why?
|
Humans | 152 | 2024 | 760613 | 0.340 |
Why?
|
Consensus | 5 | 2023 | 3113 | 0.330 |
Why?
|
Infratentorial Neoplasms | 3 | 2024 | 98 | 0.330 |
Why?
|
Gene Amplification | 1 | 2013 | 1085 | 0.320 |
Why?
|
RNA-Binding Proteins | 3 | 2017 | 1894 | 0.320 |
Why?
|
Astrocytoma | 3 | 2013 | 775 | 0.320 |
Why?
|
Guanine | 1 | 2010 | 278 | 0.320 |
Why?
|
Glutamates | 1 | 2010 | 391 | 0.310 |
Why?
|
Molecular Imaging | 1 | 2015 | 818 | 0.310 |
Why?
|
Adenocarcinoma | 5 | 2024 | 6316 | 0.310 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2019 | 3604 | 0.300 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 4 | 2015 | 1137 | 0.290 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2022 | 9278 | 0.290 |
Why?
|
Kaplan-Meier Estimate | 13 | 2020 | 6544 | 0.280 |
Why?
|
Nerve Tissue Proteins | 8 | 2019 | 4408 | 0.280 |
Why?
|
Proteoglycans | 2 | 2009 | 801 | 0.270 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2010 | 640 | 0.260 |
Why?
|
Female | 84 | 2024 | 391246 | 0.260 |
Why?
|
Mutation | 20 | 2022 | 29957 | 0.260 |
Why?
|
Nuclear Medicine | 2 | 2020 | 236 | 0.260 |
Why?
|
Egg Proteins | 4 | 1996 | 57 | 0.260 |
Why?
|
Signal Transduction | 18 | 2021 | 23374 | 0.260 |
Why?
|
Tuberous Sclerosis | 4 | 2011 | 1030 | 0.250 |
Why?
|
Organometallic Compounds | 2 | 2020 | 662 | 0.250 |
Why?
|
Cell Proliferation | 16 | 2020 | 10442 | 0.250 |
Why?
|
Central Nervous System | 3 | 2014 | 1334 | 0.250 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2022 | 1596 | 0.250 |
Why?
|
Cell Line, Tumor | 21 | 2023 | 16932 | 0.250 |
Why?
|
Cerebral Ventricle Neoplasms | 1 | 2004 | 44 | 0.240 |
Why?
|
Societies, Medical | 5 | 2020 | 3905 | 0.240 |
Why?
|
Cerebellum | 5 | 2022 | 1495 | 0.240 |
Why?
|
Male | 72 | 2024 | 359718 | 0.240 |
Why?
|
Otx Transcription Factors | 2 | 2022 | 42 | 0.230 |
Why?
|
Somatostatin | 4 | 2023 | 447 | 0.230 |
Why?
|
Vestibular Diseases | 1 | 2006 | 229 | 0.230 |
Why?
|
Colonic Neoplasms | 3 | 2014 | 2526 | 0.230 |
Why?
|
Mitosis | 1 | 2009 | 1191 | 0.220 |
Why?
|
Lateral Ventricles | 1 | 2004 | 146 | 0.220 |
Why?
|
North America | 3 | 2023 | 1284 | 0.220 |
Why?
|
Mice, SCID | 7 | 2020 | 2627 | 0.220 |
Why?
|
Metencephalon | 1 | 2022 | 2 | 0.210 |
Why?
|
Mice | 38 | 2024 | 81209 | 0.210 |
Why?
|
DNA Methylation | 10 | 2019 | 4372 | 0.210 |
Why?
|
ras Proteins | 3 | 2015 | 1051 | 0.210 |
Why?
|
Consensus Development Conferences as Topic | 2 | 2020 | 169 | 0.210 |
Why?
|
Neurogenesis | 3 | 2021 | 855 | 0.200 |
Why?
|
Hypertension | 1 | 2022 | 8595 | 0.200 |
Why?
|
Antibodies, Monoclonal | 5 | 2012 | 9185 | 0.200 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2023 | 951 | 0.200 |
Why?
|
Contraception, Immunologic | 3 | 1996 | 5 | 0.190 |
Why?
|
Succinate Dehydrogenase | 1 | 2022 | 145 | 0.190 |
Why?
|
Protein Kinases | 2 | 2008 | 1612 | 0.190 |
Why?
|
Tumor Cells, Cultured | 8 | 2020 | 6130 | 0.190 |
Why?
|
Neurilemmoma | 1 | 2006 | 523 | 0.190 |
Why?
|
Esophagogastric Junction | 2 | 2024 | 341 | 0.190 |
Why?
|
Radiation Genetics | 1 | 2020 | 16 | 0.190 |
Why?
|
Middle Aged | 45 | 2024 | 220359 | 0.190 |
Why?
|
Neurons | 7 | 2019 | 9424 | 0.190 |
Why?
|
Alpha Particles | 1 | 2020 | 29 | 0.180 |
Why?
|
Chromosomes, Human, Pair 1 | 3 | 2012 | 635 | 0.180 |
Why?
|
Embryo, Mammalian | 3 | 2019 | 1674 | 0.180 |
Why?
|
Prognosis | 13 | 2021 | 29661 | 0.180 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2017 | 4571 | 0.180 |
Why?
|
DNA Repair | 2 | 2020 | 2038 | 0.180 |
Why?
|
Gene Expression Profiling | 13 | 2019 | 9406 | 0.180 |
Why?
|
Receptors, Somatostatin | 2 | 2018 | 136 | 0.180 |
Why?
|
Central Nervous System Neoplasms | 2 | 2020 | 916 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 3 | 2022 | 5640 | 0.180 |
Why?
|
DNA Copy Number Variations | 4 | 2018 | 2013 | 0.180 |
Why?
|
Estrogen Replacement Therapy | 1 | 2006 | 1206 | 0.170 |
Why?
|
Anus Neoplasms | 1 | 2024 | 329 | 0.170 |
Why?
|
DNA Damage | 2 | 2020 | 2442 | 0.170 |
Why?
|
Phenylurea Compounds | 2 | 2013 | 529 | 0.170 |
Why?
|
Cell Differentiation | 7 | 2022 | 11481 | 0.170 |
Why?
|
Aged | 36 | 2024 | 169143 | 0.170 |
Why?
|
RNA, Small Nuclear | 1 | 2019 | 74 | 0.170 |
Why?
|
Animals | 41 | 2024 | 167960 | 0.160 |
Why?
|
Adult | 39 | 2024 | 220007 | 0.160 |
Why?
|
Mesencephalon | 1 | 2021 | 332 | 0.160 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2022 | 2505 | 0.160 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2021 | 458 | 0.160 |
Why?
|
Brain Stem Neoplasms | 2 | 2013 | 190 | 0.160 |
Why?
|
Receptors, Peptide | 1 | 2020 | 279 | 0.150 |
Why?
|
Genomic Structural Variation | 2 | 2022 | 63 | 0.150 |
Why?
|
Genomics | 6 | 2023 | 5795 | 0.150 |
Why?
|
Tumor Suppressor Proteins | 4 | 2011 | 2802 | 0.150 |
Why?
|
Pteridines | 1 | 2017 | 47 | 0.150 |
Why?
|
Eligibility Determination | 1 | 2021 | 419 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2020 | 5251 | 0.150 |
Why?
|
Dactinomycin | 1 | 2017 | 304 | 0.150 |
Why?
|
Topotecan | 1 | 2017 | 132 | 0.150 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 1617 | 0.150 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2009 | 452 | 0.150 |
Why?
|
Drug Delivery Systems | 2 | 2017 | 2221 | 0.140 |
Why?
|
Malignant Carcinoid Syndrome | 1 | 2017 | 30 | 0.140 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2018 | 198 | 0.140 |
Why?
|
Arsenicals | 1 | 2017 | 117 | 0.140 |
Why?
|
Neoplasm Metastasis | 6 | 2023 | 4902 | 0.140 |
Why?
|
MAP Kinase Signaling System | 2 | 2014 | 1483 | 0.140 |
Why?
|
Prosencephalon | 1 | 2019 | 305 | 0.140 |
Why?
|
Neoplasm Invasiveness | 2 | 2024 | 3618 | 0.140 |
Why?
|
Neoplasm Staging | 12 | 2019 | 11152 | 0.140 |
Why?
|
Aged, 80 and over | 17 | 2021 | 58980 | 0.140 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2020 | 423 | 0.140 |
Why?
|
Vitamins | 2 | 2019 | 1634 | 0.140 |
Why?
|
Oncolytic Viruses | 1 | 2020 | 343 | 0.140 |
Why?
|
STAT3 Transcription Factor | 3 | 2022 | 877 | 0.140 |
Why?
|
Survival Rate | 8 | 2020 | 12810 | 0.140 |
Why?
|
Nerve Degeneration | 1 | 2021 | 748 | 0.140 |
Why?
|
Child, Preschool | 17 | 2021 | 42056 | 0.130 |
Why?
|
Genomic Instability | 1 | 2020 | 704 | 0.130 |
Why?
|
Diarrhea | 2 | 2020 | 1319 | 0.130 |
Why?
|
Apoptosis | 6 | 2020 | 9497 | 0.130 |
Why?
|
Hospice Care | 1 | 2023 | 692 | 0.130 |
Why?
|
Treatment Outcome | 16 | 2024 | 64981 | 0.130 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2016 | 184 | 0.130 |
Why?
|
Bronchial Neoplasms | 1 | 2016 | 110 | 0.130 |
Why?
|
Receptors, Cell Surface | 4 | 1996 | 2825 | 0.130 |
Why?
|
Oxides | 1 | 2017 | 401 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 4 | 2013 | 4496 | 0.130 |
Why?
|
Cyclin D1 | 1 | 2017 | 451 | 0.130 |
Why?
|
Microsatellite Instability | 2 | 2010 | 715 | 0.130 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2017 | 2299 | 0.130 |
Why?
|
Oligopeptides | 1 | 2020 | 1187 | 0.120 |
Why?
|
Oligodendroglia | 1 | 2019 | 536 | 0.120 |
Why?
|
Oncolytic Virotherapy | 1 | 2020 | 515 | 0.120 |
Why?
|
Receptor, trkC | 1 | 2014 | 63 | 0.120 |
Why?
|
Chromosomes, Human, Pair 10 | 2 | 2018 | 276 | 0.120 |
Why?
|
Vaccines, Synthetic | 3 | 1996 | 617 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2017 | 346 | 0.120 |
Why?
|
Blotting, Western | 4 | 2017 | 5039 | 0.120 |
Why?
|
Drug Administration Schedule | 2 | 2013 | 4899 | 0.120 |
Why?
|
Combined Modality Therapy | 4 | 2016 | 8552 | 0.120 |
Why?
|
Oncogenes | 3 | 2020 | 1220 | 0.120 |
Why?
|
Proportional Hazards Models | 7 | 2020 | 12531 | 0.120 |
Why?
|
Trans-Activators | 3 | 2013 | 2860 | 0.120 |
Why?
|
Cell Division | 2 | 2021 | 4463 | 0.120 |
Why?
|
Membrane Glycoproteins | 4 | 1996 | 3709 | 0.120 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2019 | 633 | 0.120 |
Why?
|
Triazoles | 1 | 2020 | 904 | 0.120 |
Why?
|
Single-Cell Analysis | 2 | 2023 | 2380 | 0.120 |
Why?
|
Child | 22 | 2024 | 79799 | 0.120 |
Why?
|
Receptor, trkB | 1 | 2014 | 125 | 0.110 |
Why?
|
Cholecalciferol | 1 | 2019 | 550 | 0.110 |
Why?
|
Retinoblastoma Protein | 1 | 2017 | 670 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2017 | 556 | 0.110 |
Why?
|
Receptor, erbB-2 | 1 | 2024 | 2554 | 0.110 |
Why?
|
Infant | 13 | 2024 | 36053 | 0.110 |
Why?
|
Dopamine | 1 | 2021 | 1595 | 0.110 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2012 | 748 | 0.110 |
Why?
|
Maximum Tolerated Dose | 2 | 2013 | 877 | 0.110 |
Why?
|
Glypicans | 1 | 2013 | 33 | 0.110 |
Why?
|
Hypothalamic Neoplasms | 1 | 2013 | 21 | 0.110 |
Why?
|
Survival Analysis | 6 | 2020 | 10185 | 0.110 |
Why?
|
Gene Silencing | 2 | 2013 | 1512 | 0.110 |
Why?
|
DNA Helicases | 1 | 2019 | 854 | 0.110 |
Why?
|
Mice, Inbred NOD | 2 | 2017 | 1837 | 0.110 |
Why?
|
Immunohistochemistry | 10 | 2017 | 11070 | 0.110 |
Why?
|
Hepatectomy | 1 | 2017 | 559 | 0.110 |
Why?
|
Benzimidazoles | 1 | 2018 | 858 | 0.110 |
Why?
|
Immunoenzyme Techniques | 2 | 2013 | 1705 | 0.110 |
Why?
|
Quinoxalines | 1 | 2015 | 297 | 0.110 |
Why?
|
Glutarates | 1 | 2014 | 244 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 1539 | 0.100 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2013 | 412 | 0.100 |
Why?
|
Autoantibodies | 3 | 2005 | 2119 | 0.100 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2014 | 321 | 0.100 |
Why?
|
Nuclear Proteins | 3 | 2021 | 5795 | 0.100 |
Why?
|
Spinal Cord Neoplasms | 1 | 2014 | 264 | 0.100 |
Why?
|
Intestine, Small | 1 | 2018 | 1207 | 0.100 |
Why?
|
Folic Acid | 2 | 2010 | 1309 | 0.100 |
Why?
|
Wnt Proteins | 2 | 2014 | 719 | 0.100 |
Why?
|
Liver Neoplasms | 3 | 2017 | 4319 | 0.100 |
Why?
|
Cohort Studies | 15 | 2021 | 41337 | 0.100 |
Why?
|
Genes, myc | 2 | 2012 | 395 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1607 | 0.100 |
Why?
|
Genes, Tumor Suppressor | 2 | 2008 | 1055 | 0.100 |
Why?
|
Hypothalamic Diseases | 1 | 2013 | 134 | 0.100 |
Why?
|
Retrospective Studies | 11 | 2024 | 80345 | 0.100 |
Why?
|
Nerve Growth Factors | 1 | 2014 | 562 | 0.100 |
Why?
|
Germ-Line Mutation | 2 | 2018 | 1842 | 0.100 |
Why?
|
Fetus | 1 | 2019 | 1859 | 0.100 |
Why?
|
Vinblastine | 1 | 2013 | 487 | 0.100 |
Why?
|
Radiotherapy | 1 | 2018 | 1504 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1888 | 0.100 |
Why?
|
Stem Cells | 4 | 2015 | 3524 | 0.090 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1613 | 0.090 |
Why?
|
Young Adult | 13 | 2021 | 58748 | 0.090 |
Why?
|
Bromodeoxyuridine | 2 | 2009 | 311 | 0.090 |
Why?
|
Oxidative Stress | 2 | 2020 | 3106 | 0.090 |
Why?
|
Astrocytes | 1 | 2019 | 1337 | 0.090 |
Why?
|
Genes, ras | 1 | 2014 | 654 | 0.090 |
Why?
|
Prostatic Secretory Proteins | 1 | 2010 | 24 | 0.090 |
Why?
|
Prospective Studies | 12 | 2024 | 54306 | 0.090 |
Why?
|
Epigenomics | 1 | 2016 | 936 | 0.090 |
Why?
|
Niacinamide | 1 | 2013 | 414 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 5 | 2018 | 17790 | 0.090 |
Why?
|
Mice, Nude | 5 | 2020 | 3607 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2873 | 0.090 |
Why?
|
Evolution, Molecular | 1 | 2019 | 1885 | 0.090 |
Why?
|
Adolescent | 17 | 2021 | 87809 | 0.090 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2014 | 503 | 0.090 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2010 | 61 | 0.090 |
Why?
|
Receptors, CXCR4 | 2 | 2006 | 728 | 0.090 |
Why?
|
Patient Selection | 2 | 2020 | 4279 | 0.090 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 1 | 2010 | 28 | 0.090 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2012 | 410 | 0.090 |
Why?
|
Receptors, Notch | 1 | 2015 | 742 | 0.090 |
Why?
|
In Situ Nick-End Labeling | 2 | 2009 | 613 | 0.090 |
Why?
|
Receptors, Prostaglandin E | 1 | 2010 | 56 | 0.090 |
Why?
|
Lymph Node Excision | 1 | 2016 | 1303 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 2 | 2010 | 2049 | 0.090 |
Why?
|
Hydroxychloroquine | 1 | 2014 | 427 | 0.090 |
Why?
|
Up-Regulation | 1 | 2019 | 4122 | 0.090 |
Why?
|
Medical Oncology | 2 | 2023 | 2313 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 620 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 2022 | 642 | 0.090 |
Why?
|
Carcinoma, Basal Cell | 1 | 2015 | 559 | 0.080 |
Why?
|
Chromatin | 2 | 2023 | 2938 | 0.080 |
Why?
|
Radiopharmaceuticals | 2 | 2009 | 2634 | 0.080 |
Why?
|
Survival | 1 | 2010 | 161 | 0.080 |
Why?
|
beta Catenin | 3 | 2010 | 1043 | 0.080 |
Why?
|
Oophoritis | 2 | 1996 | 4 | 0.080 |
Why?
|
Cell Cycle | 3 | 2020 | 2935 | 0.080 |
Why?
|
Glycosylphosphatidylinositols | 1 | 2009 | 90 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8055 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2013 | 626 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 2018 | 1249 | 0.080 |
Why?
|
Cell Survival | 5 | 2019 | 5797 | 0.080 |
Why?
|
DNA-Binding Proteins | 3 | 2019 | 9591 | 0.080 |
Why?
|
Endothelial Growth Factors | 1 | 2001 | 673 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2013 | 2864 | 0.080 |
Why?
|
Telomerase | 1 | 2013 | 747 | 0.080 |
Why?
|
Somatomedins | 1 | 2008 | 178 | 0.080 |
Why?
|
Neocortex | 1 | 2012 | 416 | 0.080 |
Why?
|
Transcription, Genetic | 3 | 2019 | 7593 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2024 | 4024 | 0.080 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 11902 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2014 | 995 | 0.080 |
Why?
|
Models, Genetic | 1 | 2018 | 3442 | 0.080 |
Why?
|
Nitric Oxide Synthase | 1 | 2001 | 908 | 0.070 |
Why?
|
Lymphokines | 1 | 2001 | 927 | 0.070 |
Why?
|
MutS Homolog 2 Protein | 1 | 2008 | 195 | 0.070 |
Why?
|
Biliary Tract Neoplasms | 1 | 2009 | 184 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2015 | 1245 | 0.070 |
Why?
|
Ribosomal Protein S6 Kinases | 2 | 2004 | 203 | 0.070 |
Why?
|
Vitamin B Complex | 1 | 2010 | 297 | 0.070 |
Why?
|
Quinolines | 1 | 2013 | 759 | 0.070 |
Why?
|
Cerebral Cortex | 2 | 2014 | 5761 | 0.070 |
Why?
|
Chromosome Deletion | 1 | 2012 | 1387 | 0.070 |
Why?
|
Capillary Permeability | 1 | 2001 | 768 | 0.070 |
Why?
|
Phosphorylation | 5 | 2017 | 8311 | 0.070 |
Why?
|
Disease Progression | 4 | 2024 | 13505 | 0.070 |
Why?
|
Mice, Knockout | 3 | 2019 | 14374 | 0.070 |
Why?
|
Vitamin B 12 | 1 | 2010 | 522 | 0.070 |
Why?
|
Insulin | 2 | 2013 | 6596 | 0.070 |
Why?
|
Forecasting | 1 | 2015 | 2931 | 0.070 |
Why?
|
Mice, Transgenic | 4 | 2017 | 9530 | 0.070 |
Why?
|
Pyrimidines | 2 | 2016 | 3016 | 0.070 |
Why?
|
Point Mutation | 1 | 2011 | 1594 | 0.070 |
Why?
|
Zona Pellucida | 1 | 1996 | 14 | 0.070 |
Why?
|
Lymph Nodes | 2 | 2016 | 3486 | 0.070 |
Why?
|
Cell Culture Techniques | 1 | 2013 | 1664 | 0.070 |
Why?
|
Animals, Newborn | 2 | 2009 | 2671 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3392 | 0.070 |
Why?
|
Autophagy | 1 | 2014 | 1337 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3448 | 0.070 |
Why?
|
Ear Canal | 1 | 2006 | 146 | 0.070 |
Why?
|
Histones | 2 | 2023 | 2582 | 0.070 |
Why?
|
Translocation, Genetic | 3 | 2022 | 1388 | 0.060 |
Why?
|
Genome, Human | 2 | 2024 | 4418 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 6180 | 0.060 |
Why?
|
Myelin-Associated Glycoprotein | 1 | 2005 | 107 | 0.060 |
Why?
|
Tamoxifen | 1 | 2010 | 963 | 0.060 |
Why?
|
CpG Islands | 1 | 2010 | 1221 | 0.060 |
Why?
|
Sulfonamides | 1 | 2015 | 1977 | 0.060 |
Why?
|
Recurrence | 3 | 2019 | 8483 | 0.060 |
Why?
|
Geriatric Assessment | 1 | 2013 | 1405 | 0.060 |
Why?
|
Leucovorin | 2 | 2019 | 641 | 0.060 |
Why?
|
DNA Mismatch Repair | 1 | 2008 | 429 | 0.060 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2008 | 656 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2017 | 2325 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3531 | 0.060 |
Why?
|
Ribosomal Protein S6 | 1 | 2004 | 71 | 0.060 |
Why?
|
Rhabdomyoma | 1 | 2004 | 54 | 0.060 |
Why?
|
Tumor Burden | 3 | 2017 | 1895 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2282 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2013 | 5201 | 0.060 |
Why?
|
Mice, Mutant Strains | 2 | 2021 | 1754 | 0.060 |
Why?
|
Body Patterning | 1 | 2009 | 632 | 0.060 |
Why?
|
Ovarian Diseases | 1 | 1996 | 137 | 0.060 |
Why?
|
Pyrazoles | 1 | 2015 | 1999 | 0.060 |
Why?
|
Risk Factors | 12 | 2021 | 74333 | 0.060 |
Why?
|
Ovary | 2 | 1996 | 958 | 0.060 |
Why?
|
Population Surveillance | 1 | 2014 | 2608 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2014 | 3530 | 0.060 |
Why?
|
Muscle Cells | 1 | 2004 | 195 | 0.060 |
Why?
|
Anilides | 2 | 2018 | 409 | 0.060 |
Why?
|
Neovascularization, Physiologic | 1 | 2001 | 1336 | 0.060 |
Why?
|
Alleles | 4 | 2013 | 6900 | 0.060 |
Why?
|
Precancerous Conditions | 1 | 2010 | 977 | 0.060 |
Why?
|
Autoimmune Diseases | 2 | 1996 | 2250 | 0.060 |
Why?
|
Organoplatinum Compounds | 2 | 2019 | 410 | 0.050 |
Why?
|
Physical Exertion | 1 | 2006 | 662 | 0.050 |
Why?
|
Data Collection | 1 | 2013 | 3315 | 0.050 |
Why?
|
Indoles | 2 | 2009 | 1829 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2017 | 2758 | 0.050 |
Why?
|
Estradiol | 1 | 2010 | 1932 | 0.050 |
Why?
|
Transcription Factors | 2 | 2022 | 12102 | 0.050 |
Why?
|
Neoplasms | 3 | 2021 | 22075 | 0.050 |
Why?
|
Core Binding Factor alpha Subunits | 1 | 2022 | 25 | 0.050 |
Why?
|
DNA Mutational Analysis | 3 | 2018 | 4108 | 0.050 |
Why?
|
In Situ Hybridization | 3 | 2014 | 1900 | 0.050 |
Why?
|
Pyrroles | 1 | 2009 | 1137 | 0.050 |
Why?
|
Quality of Life | 2 | 2023 | 13308 | 0.050 |
Why?
|
Dexamethasone | 1 | 2010 | 1927 | 0.050 |
Why?
|
Aspirin | 1 | 2014 | 3364 | 0.050 |
Why?
|
Loss of Heterozygosity | 1 | 2004 | 659 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5782 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2023 | 296 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2005 | 588 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4538 | 0.050 |
Why?
|
HEK293 Cells | 3 | 2019 | 4263 | 0.050 |
Why?
|
PTEN Phosphohydrolase | 1 | 2008 | 1115 | 0.050 |
Why?
|
Fluorouracil | 2 | 2019 | 1631 | 0.050 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2002 | 33 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8652 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12968 | 0.050 |
Why?
|
Electroporation | 2 | 2014 | 255 | 0.050 |
Why?
|
Heparin | 1 | 2009 | 1652 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2011 | 2053 | 0.050 |
Why?
|
United States | 6 | 2023 | 72448 | 0.050 |
Why?
|
SEER Program | 2 | 2017 | 1530 | 0.050 |
Why?
|
Heart Neoplasms | 1 | 2004 | 360 | 0.050 |
Why?
|
Gene Expression | 2 | 2016 | 7587 | 0.050 |
Why?
|
Radiography | 1 | 2012 | 6965 | 0.050 |
Why?
|
Genetic Loci | 1 | 2010 | 2618 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2016 | 3774 | 0.050 |
Why?
|
Comparative Genomic Hybridization | 2 | 2013 | 473 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2009 | 2007 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2019 | 15790 | 0.050 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 22020 | 0.050 |
Why?
|
Multigene Family | 2 | 2014 | 1077 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 631 | 0.040 |
Why?
|
Cell Movement | 2 | 2018 | 5206 | 0.040 |
Why?
|
Formaldehyde | 2 | 2012 | 358 | 0.040 |
Why?
|
Immunoprecipitation | 2 | 2014 | 877 | 0.040 |
Why?
|
Protein Binding | 2 | 2009 | 9335 | 0.040 |
Why?
|
T-Box Domain Proteins | 1 | 2022 | 468 | 0.040 |
Why?
|
Camptothecin | 2 | 2014 | 590 | 0.040 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2943 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 323 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 4167 | 0.040 |
Why?
|
Dyspepsia | 1 | 2020 | 118 | 0.040 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2019 | 108 | 0.040 |
Why?
|
Autoantigens | 1 | 1994 | 877 | 0.040 |
Why?
|
Infertility, Female | 1 | 1995 | 759 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2019 | 3442 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18137 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 2 | 2015 | 1078 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2017 | 2698 | 0.040 |
Why?
|
Infertility | 1 | 1996 | 655 | 0.040 |
Why?
|
Paraffin Embedding | 2 | 2011 | 302 | 0.040 |
Why?
|
Fibrinolytic Agents | 1 | 2009 | 2167 | 0.040 |
Why?
|
Immunity, Cellular | 2 | 2020 | 1557 | 0.040 |
Why?
|
Gastritis | 1 | 2020 | 198 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 12762 | 0.040 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2018 | 56 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 15286 | 0.040 |
Why?
|
Consent Forms | 1 | 2018 | 55 | 0.040 |
Why?
|
RNA Splice Sites | 1 | 2019 | 211 | 0.040 |
Why?
|
Annexin A5 | 1 | 2018 | 103 | 0.040 |
Why?
|
Parabiosis | 1 | 2018 | 64 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2019 | 428 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 611 | 0.040 |
Why?
|
Heredity | 1 | 2018 | 148 | 0.040 |
Why?
|
Ribonuclease III | 1 | 2019 | 279 | 0.040 |
Why?
|
Mitotic Index | 1 | 2017 | 161 | 0.040 |
Why?
|
Postmenopause | 1 | 2006 | 2509 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2896 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2020 | 350 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2012 | 858 | 0.040 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2017 | 74 | 0.040 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 2017 | 93 | 0.040 |
Why?
|
Transfection | 1 | 2005 | 5781 | 0.040 |
Why?
|
Depression | 1 | 2017 | 8045 | 0.040 |
Why?
|
Flushing | 1 | 2017 | 52 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2022 | 1152 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2010 | 11345 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3759 | 0.030 |
Why?
|
Macrophages | 2 | 2023 | 5745 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2019 | 383 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2013 | 7850 | 0.030 |
Why?
|
Cell Nucleus | 2 | 2020 | 2907 | 0.030 |
Why?
|
T-Lymphocytes | 4 | 2020 | 10181 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3332 | 0.030 |
Why?
|
Motor Activity | 1 | 2006 | 2688 | 0.030 |
Why?
|
Amino Acid Sequence | 5 | 2005 | 13451 | 0.030 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2002 | 608 | 0.030 |
Why?
|
Age Factors | 3 | 2018 | 18413 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2010 | 10343 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2011 | 2829 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 2018 | 605 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2018 | 747 | 0.030 |
Why?
|
H-2 Antigens | 2 | 1996 | 358 | 0.030 |
Why?
|
Mass Spectrometry | 2 | 2014 | 2192 | 0.030 |
Why?
|
Molecular Sequence Data | 5 | 2005 | 17624 | 0.030 |
Why?
|
Vaccines | 1 | 1994 | 832 | 0.030 |
Why?
|
Alberta | 1 | 2014 | 66 | 0.030 |
Why?
|
Irritable Bowel Syndrome | 1 | 2020 | 453 | 0.030 |
Why?
|
Pyridines | 2 | 2018 | 2879 | 0.030 |
Why?
|
Proteins | 2 | 2012 | 6029 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2222 | 0.030 |
Why?
|
Cells, Cultured | 4 | 2014 | 18955 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2019 | 12427 | 0.030 |
Why?
|
RNA Splicing | 1 | 2019 | 915 | 0.030 |
Why?
|
Deoxycytidine | 2 | 2009 | 872 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12159 | 0.030 |
Why?
|
Odds Ratio | 3 | 2014 | 9716 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2015 | 104 | 0.030 |
Why?
|
Lasers | 1 | 2019 | 952 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2019 | 1091 | 0.030 |
Why?
|
HeLa Cells | 1 | 2020 | 3105 | 0.030 |
Why?
|
Benzylamines | 2 | 2006 | 248 | 0.030 |
Why?
|
Heterocyclic Compounds | 2 | 2006 | 247 | 0.030 |
Why?
|
Pancreas | 1 | 2021 | 1677 | 0.030 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2013 | 73 | 0.030 |
Why?
|
Thromboplastin | 1 | 2015 | 286 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2017 | 675 | 0.030 |
Why?
|
Cytogenetics | 1 | 2014 | 198 | 0.030 |
Why?
|
Cell Lineage | 1 | 2022 | 2532 | 0.030 |
Why?
|
Chromogranin A | 1 | 2013 | 49 | 0.030 |
Why?
|
Indazoles | 1 | 2015 | 302 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 2010 | 2014 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2014 | 286 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 6465 | 0.030 |
Why?
|
Transforming Growth Factor beta | 2 | 2012 | 1959 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2011 | 1728 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 1996 | 1763 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2013 | 165 | 0.030 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2014 | 410 | 0.030 |
Why?
|
Lymphoma | 1 | 2002 | 1899 | 0.030 |
Why?
|
Interferon-alpha | 1 | 2017 | 919 | 0.030 |
Why?
|
Paraffin | 1 | 2012 | 37 | 0.030 |
Why?
|
Vertebrates | 1 | 2014 | 228 | 0.030 |
Why?
|
Helix-Loop-Helix Motifs | 1 | 2012 | 96 | 0.030 |
Why?
|
Disease Management | 1 | 2023 | 2514 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3617 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1741 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2014 | 551 | 0.030 |
Why?
|
Myocardium | 1 | 2004 | 4700 | 0.020 |
Why?
|
Microglia | 1 | 2020 | 1350 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 724 | 0.020 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 666 | 0.020 |
Why?
|
Sex Factors | 2 | 2016 | 10546 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2012 | 645 | 0.020 |
Why?
|
3T3 Cells | 1 | 2013 | 1085 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2018 | 1431 | 0.020 |
Why?
|
COS Cells | 1 | 2013 | 1129 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2203 | 0.020 |
Why?
|
Gene Duplication | 1 | 2012 | 314 | 0.020 |
Why?
|
DNA, Neoplasm | 2 | 2009 | 1745 | 0.020 |
Why?
|
Hydroxyestrones | 1 | 2010 | 17 | 0.020 |
Why?
|
Half-Life | 1 | 2012 | 652 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2005 | 0.020 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2018 | 938 | 0.020 |
Why?
|
Ganglia, Spinal | 1 | 2014 | 523 | 0.020 |
Why?
|
Gene Fusion | 1 | 2013 | 354 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 2138 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6065 | 0.020 |
Why?
|
Dimerization | 1 | 2012 | 891 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2471 | 0.020 |
Why?
|
Canada | 1 | 2016 | 2126 | 0.020 |
Why?
|
Genotype | 2 | 2016 | 12957 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4578 | 0.020 |
Why?
|
Receptors, Prostaglandin E, EP2 Subtype | 1 | 2010 | 49 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 2913 | 0.020 |
Why?
|
Blood Circulation | 1 | 2001 | 249 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7233 | 0.020 |
Why?
|
Ear, Inner | 1 | 2014 | 424 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2020 | 2698 | 0.020 |
Why?
|
Exercise | 1 | 2006 | 5787 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2010 | 21029 | 0.020 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2001 | 514 | 0.020 |
Why?
|
Isoenzymes | 1 | 2013 | 1690 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2009 | 138 | 0.020 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2009 | 152 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2013 | 1697 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2008 | 48 | 0.020 |
Why?
|
Oncogene Protein v-akt | 1 | 2008 | 129 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39262 | 0.020 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2008 | 15 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2008 | 125 | 0.020 |
Why?
|
Patient Dropouts | 1 | 2010 | 412 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2012 | 1529 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2011 | 2558 | 0.020 |
Why?
|
Palliative Care | 1 | 2023 | 3607 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20080 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2001 | 704 | 0.020 |
Why?
|
Cell Line | 1 | 2022 | 15620 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 206 | 0.020 |
Why?
|
Risk | 2 | 2010 | 9632 | 0.020 |
Why?
|
Tissue Fixation | 1 | 2008 | 241 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 3725 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2010 | 599 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6538 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2008 | 2448 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3302 | 0.020 |
Why?
|
C-Peptide | 1 | 2008 | 433 | 0.020 |
Why?
|
Carmustine | 1 | 2006 | 138 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2008 | 415 | 0.020 |
Why?
|
Protons | 1 | 2012 | 1114 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10826 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4169 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16548 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2009 | 748 | 0.020 |
Why?
|
Laminin | 1 | 2008 | 405 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 40139 | 0.020 |
Why?
|
Veratrum Alkaloids | 1 | 2005 | 23 | 0.020 |
Why?
|
Lymphocytes | 1 | 2014 | 2611 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3800 | 0.020 |
Why?
|
Risk Assessment | 3 | 2014 | 24102 | 0.020 |
Why?
|
Litter Size | 1 | 1995 | 49 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2010 | 1493 | 0.020 |
Why?
|
Fluoroimmunoassay | 1 | 2005 | 30 | 0.020 |
Why?
|
Mice, Inbred A | 1 | 1995 | 246 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6552 | 0.020 |
Why?
|
Quinazolines | 1 | 2012 | 1363 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7344 | 0.020 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 1 | 2005 | 38 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3291 | 0.020 |
Why?
|
Binding Sites, Antibody | 1 | 2005 | 337 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3696 | 0.020 |
Why?
|
Developmental Disabilities | 1 | 2014 | 1504 | 0.020 |
Why?
|
Epitope Mapping | 1 | 1996 | 297 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2005 | 865 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2818 | 0.020 |
Why?
|
Myosin Light Chains | 1 | 2004 | 121 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6238 | 0.010 |
Why?
|
Phosphotransferases | 1 | 2005 | 303 | 0.010 |
Why?
|
Myelin Proteins | 1 | 2005 | 208 | 0.010 |
Why?
|
Solutions | 1 | 2005 | 419 | 0.010 |
Why?
|
Immunoblotting | 1 | 2008 | 1649 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2015 | 26179 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 2014 | 1699 | 0.010 |
Why?
|
Oncogene Proteins | 1 | 2008 | 719 | 0.010 |
Why?
|
Cardiac Myosins | 1 | 2004 | 127 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2651 | 0.010 |
Why?
|
Glycogen | 1 | 2004 | 251 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1974 | 0.010 |
Why?
|
Gene Dosage | 1 | 2008 | 1218 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3094 | 0.010 |
Why?
|
NF-kappa B | 1 | 2012 | 2486 | 0.010 |
Why?
|
Piperidines | 1 | 2012 | 1650 | 0.010 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 12628 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2014 | 1647 | 0.010 |
Why?
|
Molecular Mimicry | 1 | 1994 | 200 | 0.010 |
Why?
|
Retina | 1 | 2014 | 2635 | 0.010 |
Why?
|
Plasmids | 1 | 2008 | 2275 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14494 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 2009 | 1356 | 0.010 |
Why?
|
Drug Synergism | 1 | 2006 | 1752 | 0.010 |
Why?
|
Integrases | 1 | 2004 | 516 | 0.010 |
Why?
|
Prostate | 1 | 2010 | 1793 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 474 | 0.010 |
Why?
|
Sural Nerve | 1 | 2002 | 105 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4716 | 0.010 |
Why?
|
Chemokines, CXC | 1 | 2003 | 421 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3465 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 478 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2001 | 2141 | 0.010 |
Why?
|
Luciferases | 1 | 2003 | 716 | 0.010 |
Why?
|
Drug Combinations | 1 | 2008 | 2025 | 0.010 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2005 | 599 | 0.010 |
Why?
|
Species Specificity | 1 | 1996 | 2418 | 0.010 |
Why?
|
Chemokine CXCL12 | 1 | 2003 | 454 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22052 | 0.010 |
Why?
|
Cell Count | 1 | 2005 | 1835 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2001 | 2414 | 0.010 |
Why?
|
Pregnancy | 2 | 2014 | 29746 | 0.010 |
Why?
|
Immunization | 1 | 1995 | 1227 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8623 | 0.010 |
Why?
|
Brain | 2 | 2023 | 26951 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2008 | 1928 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2009 | 4626 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10755 | 0.010 |
Why?
|
Neural Conduction | 1 | 2002 | 441 | 0.010 |
Why?
|
Administration, Oral | 1 | 2008 | 4035 | 0.010 |
Why?
|
Chemotaxis | 1 | 2003 | 598 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 1613 | 0.010 |
Why?
|
Prostatectomy | 1 | 2009 | 1956 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2005 | 2057 | 0.010 |
Why?
|
RNA Interference | 1 | 2008 | 2846 | 0.010 |
Why?
|
Collagen | 1 | 2008 | 2636 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2924 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 2753 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2012 | 4938 | 0.010 |
Why?
|
Decision Making | 1 | 2013 | 3925 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1246 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2010 | 3663 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 8022 | 0.010 |
Why?
|
Autoimmunity | 1 | 1995 | 1370 | 0.010 |
Why?
|
Epitopes | 1 | 1994 | 2503 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1995 | 3734 | 0.010 |
Why?
|
Nurses | 1 | 2006 | 2467 | 0.010 |
Why?
|
Models, Biological | 1 | 2011 | 9468 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5890 | 0.010 |
Why?
|
Life Style | 1 | 2006 | 3898 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2016 | 36286 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1994 | 5496 | 0.010 |
Why?
|
Liver | 1 | 2008 | 7510 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2004 | 3812 | 0.010 |
Why?
|
Base Sequence | 1 | 2003 | 12444 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 2005 | 3204 | 0.010 |
Why?
|
Biopsy | 1 | 2002 | 6771 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20509 | 0.000 |
Why?
|
Anti-HIV Agents | 1 | 2003 | 4491 | 0.000 |
Why?
|